Cigall Kadoch - 14 Dec 2021 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role: Director, 10%+ Owner
Signature: /s /Allan Reine, M.D., Attorney-in-Fact
Issuer symbol: FHTX
Transactions as of: 14 Dec 2021
Net transactions value: $0
Form type: 4
Filing time: 16 Dec 2021, 18:20:30 UTC
Previous filing: 14 Jul 2021
Next filing: 22 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FHTX	Common Stock	Gift	$0	-333,333	-53%	$0.000000	295,000	14 Dec 2021	Direct	F1
holding	FHTX	Common Stock						3,329,379	14 Dec 2021	See Footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On December 14, 2021, the Reporting Person transferred 333,333 shares of Common Stock to the Cigall Kadoch Irrevocable Trust of 2021 (the "Irrevocable Trust"). The Reporting Person is not a trustee of the Irrevocable Trust and she exercises no investment discretion with respect to trust property therein. The Reporting Person and members of her immediate family are beneficiaries of the Irrevocable Trust.
F2	Shares held by the Cigall Kadoch Revocable Trust of 2021, of which the Reporting Person is the sole trustee and sole current beneficiary.

Content

On December 14, 2021, the Reporting Person transferred 333,333 shares of Common Stock to the Cigall Kadoch Irrevocable Trust of 2021 (the "Irrevocable Trust"). The Reporting Person is not a trustee of the Irrevocable Trust and she exercises no investment discretion with respect to trust property therein. The Reporting Person and members of her immediate family are beneficiaries of the Irrevocable Trust.

Shares held by the Cigall Kadoch Revocable Trust of 2021, of which the Reporting Person is the sole trustee and sole current beneficiary.